Pacific Biosciences
PACB
PACB
201 hedge funds and large institutions have $236M invested in Pacific Biosciences in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
7% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 59
1% less funds holding
Funds holding: 204 → 201 (-3)
4.5% less ownership
Funds ownership: 66.12% → 61.63% (-4.5%)
Holders
201
Holding in Top 10
2
Calls
$2.87M
Puts
$1.02M
Top Buyers
| 1 | +$5.18M | |
| 2 | +$3.2M | |
| 3 | +$2.32M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$986K |
| 5 |
Squarepoint
New York
|
+$816K |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$6.88M | |
| 3 | -$3.44M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.34M |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.21M |
